LIQUIDIA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.53 USD | +1.29% |
|
-5.72% | +4.16% |
| 04-01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
| 04-01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 79.76 | 127.8 | 253.1 | 410.8 | 822.8 | 952.6 | - | - |
| Enterprise Value (EV) 1 | 42.14 | 74 | 207.5 | 337.4 | 822.8 | 929.9 | 1,052 | 1,179 |
| P/E ratio | -1.65 x | -1.68 x | -6.96 x | -9.51 x | -9.94 x | -11.2 x | -25.9 x | 28.5 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 9.88 x | 173 x | 19.7 x | 25.8 x | 47.1 x | 16.3 x | 5.89 x | 4.5 x |
| EV / Revenue | 5.22 x | 100 x | 16.1 x | 21.2 x | 47.1 x | 15.9 x | 6.5 x | 5.57 x |
| EV / EBITDA | - | - | - | -9.61 x | -11.6 x | -11.2 x | -44.8 x | - |
| EV / FCF | -0.84 x | -1.36 x | -6.08 x | -11.6 x | - | -16.8 x | 76.5 x | 17 x |
| FCF Yield | -119% | -73.4% | -16.5% | -8.65% | - | -5.94% | 1.31% | 5.89% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 18,657 | 43,336 | 51,978 | 64,495 | 68,397 | 76,028 | - | - |
| Reference price 2 | 4.275 | 2.950 | 4.870 | 6.370 | 12.03 | 12.53 | 12.53 | 12.53 |
| Announcement Date | 11/03/20 | 23/03/21 | 17/03/22 | 16/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8.072 | 0.7396 | 12.85 | 15.94 | 17.49 | 58.49 | 161.8 | 211.7 |
| EBITDA 1 | - | - | - | -35.12 | -71.21 | -82.67 | -23.48 | - |
| EBIT 1 | -46.82 | -59.09 | -33.8 | -38.77 | -73.38 | -83.79 | -34.23 | 48.75 |
| Operating Margin | -580.07% | -7,989.01% | -262.94% | -243.3% | -419.62% | -143.25% | -21.15% | 23.03% |
| Earnings before Tax (EBT) 1 | -47.58 | -59.76 | -34.58 | -41.02 | -78.5 | -77.13 | -21.47 | 47.01 |
| Net income 1 | -47.58 | -59.76 | -34.58 | -41.02 | -78.5 | -83.77 | -37.59 | 35.71 |
| Net margin | -589.48% | -8,080.09% | -269.02% | -257.39% | -448.89% | -143.21% | -23.23% | 16.87% |
| EPS 2 | -2.590 | -1.760 | -0.7000 | -0.6700 | -1.210 | -1.114 | -0.4833 | 0.4400 |
| Free Cash Flow 1 | -50.13 | -54.33 | -34.14 | -29.18 | - | -55.21 | 13.75 | 69.43 |
| FCF margin | -621.06% | -7,345.59% | -265.63% | -183.12% | - | -94.39% | 8.5% | 32.8% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 194.45% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 11/03/20 | 23/03/21 | 17/03/22 | 16/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3.179 | 3.215 | 3.492 | 3.918 | 3.165 | 5.36 | 4.493 | 4.786 | 3.678 | 4.531 | 4.476 | 10.06 | 16.36 | 27.58 |
| EBITDA | - | - | - | - | - | -3.416 | - | - | - | - | - | - | - | - |
| EBIT 1 | -7.08 | -11.36 | -14.47 | -8.97 | -12 | -6.497 | -9.232 | -22.82 | -14.89 | -26.44 | -22.88 | -22.53 | -22.18 | -16.21 |
| Operating Margin | -222.73% | -353.42% | -414.43% | -228.94% | -379.02% | -121.21% | -205.48% | -476.91% | -404.87% | -583.45% | -511.18% | -223.84% | -135.56% | -58.77% |
| Earnings before Tax (EBT) 1 | -7.281 | -11.56 | -15.94 | -9.447 | -9.092 | -6.533 | -11.74 | -23.52 | -15.79 | -27.45 | -21.68 | -21.73 | -19.88 | -12.56 |
| Net income 1 | -7.281 | -11.56 | -15.94 | -9.447 | -9.092 | -6.533 | -11.74 | -23.52 | -15.79 | -27.45 | -23.16 | -22.74 | -22.4 | -16.48 |
| Net margin | -229.06% | -359.66% | -456.56% | -241.12% | -287.27% | -121.88% | -261.41% | -491.37% | -429.31% | -605.83% | -517.51% | -225.95% | -136.9% | -59.76% |
| EPS 2 | -0.1400 | -0.2300 | -0.3000 | -0.1500 | -0.1400 | -0.0900 | -0.1800 | -0.3600 | -0.2400 | -0.4200 | -0.3114 | -0.3014 | -0.2914 | -0.2171 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 03/11/21 | 17/03/22 | 12/05/22 | 11/08/22 | 08/11/22 | 16/03/23 | 04/05/23 | 10/08/23 | 07/11/23 | 13/03/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | 99.5 | 227 |
| Net Cash position 1 | 37.6 | 53.8 | 45.6 | 73.4 | - | 22.8 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | -4.24 x | - |
| Free Cash Flow 1 | -50.1 | -54.3 | -34.1 | -29.2 | - | -55.2 | 13.8 | 69.4 |
| ROE (net income / shareholders' equity) | - | - | - | -51.4% | - | -171% | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share 2 | - | - | - | -0.4700 | - | -0.9200 | -0.3200 | - |
| Capex 1 | 1.85 | 0.75 | 0.11 | 0.59 | - | 1.42 | 1.43 | 1.45 |
| Capex / Sales | 22.92% | 101.68% | 0.83% | 3.72% | - | 2.42% | 0.88% | 0.68% |
| Announcement Date | 11/03/20 | 23/03/21 | 17/03/22 | 16/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12.53
USD
Average target price
23.86
USD
Spread / Average Target
+90.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.16% | 953M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- LQDA Stock
- Financials Liquidia Corporation
